T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Bio-Techne
TECH
$11.3B
| $332M | 0.05% |
4,067,429
+3,559,781
| +701% | +$286M |
|
302
KE Holdings
BEKE
$19.2B
| $329M | 0.05% |
22,178,446
-3,445,057
| -13% | -$56.2M |
|
303
Shell
SHEL
$249B
| $326M | 0.05% |
5,398,527
+289,303
| +6% | +$17.4M |
|
304
Loews
L
$23.1B
| $325M | 0.05% |
5,472,669
-43,578
| -0.8% | -$2.52M |
|
305
PUT
M&T Bank
MTB
$36.6B
| $323M | 0.05% |
+2,610,300
| New | +$316M |
|
306
Biogen
BIIB
$30.9B
| $321M | 0.04% |
1,128,642
-959,714
| -46% | -$286M |
|
307
Cameco
CCJ
$43.1B
| $320M | 0.04% |
10,228,896
+3,693,299
| +57% | +$104M |
|
308
PACCAR
PCAR
$69B
| $319M | 0.04% |
3,816,056
-131,080
| -3% | -$9.7M |
|
309
Verisk Analytics
VRSK
$23.5B
| $318M | 0.04% |
1,406,948
-32,110
| -2% | -$6.74M |
|
310
Marathon Petroleum
MPC
$97.8B
| $316M | 0.04% |
2,712,583
-37,525
| -1% | -$4.36M |
|
311
Avery Dennison
AVY
$13.7B
| $316M | 0.04% |
1,837,983
-239,615
| -12% | -$41M |
|
312
Air Products & Chemicals
APD
$67.7B
| $315M | 0.04% |
1,053,197
-468,351
| -31% | -$133M |
|
313
Cboe Global Markets
CBOE
$30.4B
| $315M | 0.04% |
2,280,184
+1,265,000
| +125% | +$173M |
|
314
Otis Worldwide
OTIS
$28.2B
| $314M | 0.04% |
3,531,887
+122,855
| +4% | +$10.4M |
|
315
Bath & Body Works
BBWI
$3.65B
| $314M | 0.04% |
8,383,184
+4,707,777
| +128% | +$172M |
|
316
Fidelity National Information Services
FIS
$21.6B
| $314M | 0.04% |
5,744,040
-1,323,040
| -19% | -$72.8M |
|
317
Insulet
PODD
$10.1B
| $313M | 0.04% |
1,085,406
-1,173,258
| -52% | -$356M |
|
|
WRK
318
DELISTED
WestRock Company
WRK
| $313M | 0.04% |
10,753,800
+1,434,973
| +15% | +$41.6M |
|
|
SWAV
319
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $311M | 0.04% |
1,091,050
-303,717
| -22% | -$84.3M |
|
320
Kanzhun
BZ
$7.19B
| $310M | 0.04% |
20,612,631
+2,109,921
| +11% | +$35.3M |
|
321
Textron
TXT
$15.3B
| $306M | 0.04% |
4,530,253
-1,082,294
| -19% | -$71.4M |
|
|
PXD
322
DELISTED
Pioneer Natural Resource Co.
PXD
| $306M | 0.04% |
1,474,744
+259,190
| +21% | +$54.6M |
|
323
Snowflake
SNOW
$115B
| $305M | 0.04% |
1,732,329
-696,201
| -29% | -$113M |
|
324
Cardinal Health
CAH
$54.5B
| $304M | 0.04% |
3,215,642
-1,424,671
| -31% | -$120M |
|
325
Automatic Data Processing
ADP
$107B
| $300M | 0.04% |
1,362,877
-31,633
| -2% | -$6.82M |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.